Isotopen Technologien München (private company)

See something wrong or missing? Let us know
Offices:Munich
Business model:B2B

Isotopen Technologien München - ITM - is a holding company that owns biotechnology and radiopharmaceutical companies.

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 479.46M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Isotopen Technologien München

Name Criteria
France AbolerIS Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Finland DelSiTech
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden iCellate
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland Nanoform Finland
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Oncomatryx
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France Owkin
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Switzerland Pharvaris
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 6
  • Total raised in a similar range: 10M+ USD
Top